Balchem Corporation
NASDAQ:BCPC · NASDAQ Global Select
+$1.03 today
Vol 0.49M · Avg 0.21M
Intrinsic Value
BCPC Intrinsic Value
Start with the valuation result. Compare the current market price with the system DCF estimate, then use the supporting sections below to decide whether the assumptions are reasonable.
Balchem Corporation
NASDAQ:BCPC · Consensus of 4 models
Sign in to unlock intrinsic value
Create a free account to unlock 5 intrinsic value valuations per week.
Monitor BCPC
Get notified when the price moves into your range
Use alerts to turn the valuation into an action plan instead of checking the stock manually.
Price Alerts
Get notified when BCPC drops below a target
Valuation History
Is BCPC cheaper or more expensive than usual?
Review how the market has valued Balchem Corporation over time before deciding whether today’s discount or premium is unusual.
Price History
Dividend-adjusted closing price
Change
+4.97%
Period High
$183.26
Period Low
$139.44
Latest
$165.92
Analyst Targets
See where analysts expect BCPC to trade next
Compare the latest consensus target range with the current share price to understand how much upside or downside Wall Street is pricing in.
Wall Street Price Targets
1-year price history with analyst consensus target
Current
$165.92
Low Target
$162.00
Avg Target
$175.50
High Target
$189.00
Upside (Avg)
+5.77%
Alternatives to BCPC
Compare Balchem Corporation with similar companies
A stock can look attractive in isolation and still be less compelling than a peer. Check competitors before committing to the thesis.
Competitors
Peer companies in the same sector
Element Solutions Inc
NYSE:ESI
$11.30B
Axalta Coating Systems Ltd.
NYSE:AXTA
$7.31B
Eldorado Gold Corporation
NYSE:EGO
$6.91B
Sasol Limited
NYSE:SSL
$6.82B
SSR Mining Inc.
NASDAQ:SSRM
$6.65B
Perimeter Solutions, Inc.
NYSE:PRM
$5.87B
Sensient Technologies Corporation
NYSE:SXT
$4.71B
Cabot Corporation
NYSE:CBT
$4.62B
H.B. Fuller Company
NYSE:FUL
$3.51B
Hawkins, Inc.
NASDAQ:HWKN
$3.33B
Fundamental Analysis
Capture the investment case and test company quality
Write down the key idea, risks, and what would change your mind. Then review growth, profitability, returns, owner payouts, and insider activity.
My Notes
Journal entries for BCPC
Sign in to keep notes
Track your buy/sell/hold decisions for every stock in your personal journal.
Quality Snapshot
Start with the numbers that compound value
Check whether earnings, revenue, equity, cash, and returns on capital are moving in the same direction as your written thesis.
Big Five Numbers
CAGR by period · ROIC shows average
| Metric | 10yr | 5yr | 3yr | 1yr |
|---|---|---|---|---|
EPS | N/A | N/A | +12.7% | +11.8% |
Revenue | N/A | N/A | +21.2% | +2.1% |
Equity | N/A | N/A | +17.1% | +17.1% |
Cash | N/A | N/A | -16.3% | +68.6% |
ROIC | N/A | 11.6% | 9.3% | 7.7% |
Analysis
Latest growth is strongest in Cash at +68.6% and weakest in Revenue at +2.1%. Three-year average ROIC is 9.3%, which helps show whether that growth is being earned efficiently.
Growth Profile
Compare historical growth with forward expectations
Strong past growth matters more when analysts still expect the business to expand without relying on one temporary driver.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +12.7% | N/A0 analysts |
| Revenue | N/A | N/A | +21.2% | +6.3% (14yr)1 analysts |
| Net Income | N/A | N/A | +14.3% | N/A1 analysts |
| EBIT | N/A | N/A | +16.3% | +9.6% (14yr)1 analysts |
Analysis
Recent growth has been strongest in Revenue at +21.2% over three years. Forward estimates point to EBIT at +9.6% (14yr), giving you a quick check on whether expectations are accelerating or cooling.
Earnings Quality
Follow revenue through to net income
Use the waterfall to see which costs, margins, and operating lines explain how much of each sales dollar becomes profit.
Stock Ticker Earnings Waterfall
NASDAQ:BCPC · Revenue to Net Income
Key Ratios
Analysis
$1.1B of revenue converted into $158.1M of net income for the selected period. Gross margin is 36.3% and net margin is 15.0%, showing how much revenue survives after costs and taxes. EPS is $4.87, tying the income statement back to per-share earnings.
Capital Efficiency
Measure how well Balchem Corporation turns capital into returns
Returns on equity, invested capital, and assets help separate durable operators from businesses that only grow by adding more capital.
Return Metrics
ROE, ROIC & ROA over time
ROE
12.3%
avg 11.5%
ROIC
11.1%
avg 8.9%
ROA
9.1%
avg 7.5%
Analysis
ROE is currently the strongest return metric at 12.3% versus its period average of 11.5%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Owner Returns
Review how cash comes back to shareholders
Dividends, buybacks, and debt paydown show whether excess cash is being reinvested, returned, or used to strengthen the balance sheet.
Shareholder Returns
Dividend, buyback & debt paydown yields
Dividend Yield (TTM)
0.58%
Buyback Yield (TTM)
2.21%
Debt Paydown (TTM)
0.00%
Total Yield (TTM)
2.79%
Analysis
Total TTM shareholder yield is 2.79% including 0.00% from debt paydown. The largest current contributor is buybacks at 2.21%, which helps show whether capital returns are coming from direct cash payouts, share count reduction, or balance sheet cleanup.
Dividend Record
Check payout durability before counting on yield
A dividend is more useful when growth, payout ratio, and free cash flow support the current yield.
Dividends
Dividend history, growth & yield
Yield
0.58%
Annual Div/Share
$0.96
Payout Ratio
19.5%
Frequency
Annual
Shareholder Yield
2.55%
Next Ex-Date
Not announced
Next Payment
—
1Y Growth
+10.3%
3Y CAGR
+10.6%
5Y CAGR
+10.6%
Dividend Payments, Annual Total (TTM) & Yield
Analysis
The current indicated dividend yield is 0.58%, with TTM dividends of $0.96 per share. Three-year dividend growth is +10.6%, which helps show whether payouts are compounding or flattening. The payout ratio is 19.5%, so compare payout growth against earnings coverage. Payments are currently annual.
Company Overview
Understand how Balchem Corporation makes money
Finish by grounding the numbers in the company profile, leadership, balance sheet, and free cash flow.
Key Information
Leadership
Put the business in management context
Company facts explain what Balchem Corporation does; leadership context helps you judge who is responsible for capital allocation and execution.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Theodore L. Harris | Chief Executive Officer, President & Chairman | $3.69M | — | 61 | $91,373.00 | 0.28% |
Carl Martin Bengtsson | Executive Vice President, Chief Financial Officer, Treasurer & GM of Animal Nutrition and Health | $1.47M | — | 49 | $27,926.00 | 0.09% |
Frederic Boned | Senior VP, Head of Digital Transformation & AI and GM of Human Nutrition & Health | $1.25M | — | 47 | $8,978.00 | 0.03% |
Hatsuki Miyata | Executive Vice President, Chief Legal Officer & Secretary | $1.22M | — | 50 | $8,745.00 | 0.03% |
Brent Tignor | Senior Vice President & Chief Human Resources Officer | $960,140.00 | — | 48 | $10,723.00 | 0.03% |
Martin Luther Reid | Senior Vice President & Chief Supply Chain Officer | $890,244.00 | — | 59 | $27,926.00 | 0.09% |
Erin L. Gilson | Vice President & Chief Accounting Officer | $560,792.00 | — | — | $46.00 | <0.01% |
Job L. van Gunsteren | Senior Vice President & GM of Specialty Products | — | — | 49 | $10,149.00 | 0.03% |
George Graham | Senior Vice President and Chief R&D Officer | — | — | 56 | $3,200.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
5
$2.34M
Net Sentiment
$2.34M
Net selling
Most Active
van Gunsteren Job Leonard
2 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 5 sells worth $2.34M over the last 12 months. That adds up to net selling of $2.34M. van Gunsteren Job Leonard was the most active insider with 2 transactions.
Financial Position
Check what supports the company underneath the income statement
The balance sheet shows liquidity, debt, asset mix, and book value quality before you rely on earnings or growth assumptions.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $72.9M |
| Receivables | $154.2M |
| Inventory | $146.7M |
| Other Current | $15.1M |
| Total Current Assets | $388.9M |
| PP&E (Net) | $318.2M |
| Goodwill | $811.5M |
| Intangible Assets | $156.5M |
| Long-term Investments | $3.6M |
| Other Non-current | $15.1M |
| Total Non-current Assets | $1.3B |
| Total Assets | $1.7B |
Analysis
Selected assets total $1.7B for Latest. The largest visible component is Goodwill at $811.5M, about 47.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Cash Generation
Finish by testing whether profit turns into cash
Free cash flow connects accounting earnings to owner earnings, showing how much cash remains after reinvestment needs.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Explore More
Continue the stock analysis
Jump to another research area for this company.